<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02793011</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00084860</org_study_id>
    <secondary_id>5K23GM104354</secondary_id>
    <nct_id>NCT02793011</nct_id>
  </id_info>
  <brief_title>Dexamethasone and Post-tonsillectomy Pain in Children</brief_title>
  <official_title>Does Dexamethasone Reduce Postoperative Pain in Pediatric Tonsillectomy Patients?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will use a prospective randomized, controlled design utilizing a single&#xD;
      preoperative dose of oral dexamethasone or placebo to achieve these specific aims:&#xD;
&#xD;
        -  Specific Aim 1: To evaluate the potential for a single preoperative dose of oral&#xD;
           dexamethasone administered the night before surgery to reduce the incidence and severity&#xD;
           of early post tonsillectomy pain (PTP) in children&#xD;
&#xD;
        -  Specific Aim 2: To prospectively evaluate differences in early PTP experience between&#xD;
           overweight/obese children and their lean peers.&#xD;
&#xD;
        -  Specific Aim 3: To determine whether circulating inflammatory markers are strongly&#xD;
           linked to PTP severity in children and whether they could be potential contributors to&#xD;
           the higher pain experienced by overweight/obese children following Tonsillectomy and or&#xD;
           Adenoidectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      (See brief summary as well)&#xD;
&#xD;
      The study will serve as a vehicle for a three-pronged approach (clinical observation,&#xD;
      biological basis and therapeutic intervention) reflects the applicants professional interest&#xD;
      in translational pediatric obesity research If the investigators find that BMI-dependent&#xD;
      disparity exists in Post Tonsillectomy Pain (PTP) and that preoperative down regulation of&#xD;
      inflammatory response with one preoperative dose of corticosteroids reduces PTP, our findings&#xD;
      should ultimately lead to improved postoperative pain management of pediatric PTP especially&#xD;
      in obese children.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">June 27, 2019</completion_date>
  <primary_completion_date type="Actual">June 27, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of moderate/severe pain(&gt;/= 4 of 10 using the Wong-Baker faces Scale) during recovery room stay</measure>
    <time_frame>0-8 hours postoperatively</time_frame>
    <description>Subjects will be evaluated in the Post Anesthesia Care Unit (PACU) until discharge home or to the unit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients requiring analgesic intervention in the PACU will differ by BMI category (normal, overweight and obese).</measure>
    <time_frame>0-8 hours postoperatively</time_frame>
    <description>Subjects will be evaluated in the Post Anesthesia Care Unit (PACU) until discharge home or to the unit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bivariate association between BMI (in Kg/m2) and serum values of inflammatory markers (CRP, TNF-alpha and IL-6) will be computed.</measure>
    <time_frame>0-8 hours postoperatively</time_frame>
    <description>Subjects will be evaluated in the Post Anesthesia Care Unit (PACU) until discharge home or to the unit.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">137</enrollment>
  <condition>Pediatric Post-tonsillectomy Pain</condition>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Liquid or capsule dexamethasone - to be taken orally the evening before scheduled tonsillectomy with or without adenoidectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo liquid or capsule to be taken orally the evening before scheduled tonsillectomy with or without adenoidectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Oral dexamethasone elixir (0.5mg/ml or 4 mg/ml) mixed with Ora-sweet or simple syrup to mask the taste. Or 1 mg or 4 mg dexamethasone capsules if age appropriate</description>
    <arm_group_label>Dexamethasone</arm_group_label>
    <other_name>corticosteroid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo liquid (Ora-sweet or simple syrup) or Placebo capsule</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled for tonsillectomy and/or adenoidectomy at University of Michigan, C. S. Mott&#xD;
             Children's Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known hypersensitivity to dexamethasone&#xD;
&#xD;
          -  Developmental delay&#xD;
&#xD;
          -  Taking chronic analgesics&#xD;
&#xD;
          -  Taking chronic systemic steroids&#xD;
&#xD;
          -  Treatment with steroids in last 30 days&#xD;
&#xD;
          -  Cushings or Prader-Willi or Nephrotic Syndromes&#xD;
&#xD;
          -  Diabetes Mellitus&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olubukola Nafiu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan, CS Mott Children's Hospital, Dept of Otolaryngology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan C.S. Mott Children's Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2016</study_first_posted>
  <last_update_submitted>September 9, 2020</last_update_submitted>
  <last_update_submitted_qc>September 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Olubukola Nafiu</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology, University of Michigan Medical School</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

